Skip to main content

Margaret Cook Swanson Colon Cancer Awareness Group

This is the group that was started on Facebook to bring awareness to HNPCC. Feel free to join this group if you are interested in raising the awareness of genetic colon cancer. We will also be investigating ways to raise funds to help those who can't afford the testing required to diagnose colon cancer.

Comments

ivy.razmus said…
Oklahoma State University is offering free colorectal cancer screeeings to qualifying Oklahomans. The university's Department of Surgery was awarded a grant to provide free screenings. The program is a collaborative effort betwen OSU center for Health Sciences in Tulsa and the Oklahoma State Health Department. To qualify for a free colonoscopy, you must be a Oklahoma resident between 50 and 64, uninsured and a legal citizen.
To see whether you qualify or to make an appointment cal 918-747-5322.

If they were aware about HNPCC they would be offering it to family members who have colon cancer that runs in the family.......as another option besides age.
We need health care providers to be as aware as health care recipients.

Working on a brochure that gives more information about HNPCC, stay tuned.
Ivy
ivy.razmus said…
LYNCH SYNDROME I
Alternative titles; symbols

COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1; HNPCC1
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1; FCC1
COCA1
LYNCH SYNDROME II, INCLUDED

Gene map locus 2p22-p21
TEXT

A number sign (#) is used with this entry because Lynch syndrome I, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is caused by heterozygous mutations in mismatch repair genes (MMR). HNPCC1 refers to the disorder caused by mutations in the MSH2 gene (609309).

HNPCC is a genetically heterogeneous disease. In addition to mutations in the MSH2 gene, mutations in the MLH1 (120436), PMS1 (600258), PMS2 (600259), MSH6 (600678), TFGBR2 (190182), and MLH3 (604395) genes have been identified in HNPCC. Since defects in the MSH2 gene may account for as many as 60% of HNPCC cases, and defects in the MLH1 gene may play a role in up to 30%, defects in these 2 genes likely account for the vast majority of HNPCC cases.
ivy.razmus said…
http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120435
ivy.razmus said…
ghr.nlm.nih.gov/condition=lynchsyndrome
ivy.razmus said…
Although the polyps do not occur in greater numbers than in the general population, they are more likely to become cancerous. Lynch Syndrome.
ivy.razmus said…
ghr.nlm.nih.gov/condition=lynchsyndrome
MD Anderson is also changing the name!
lets put the HNPCC second....Lynch Syndrome
(Hereditary Nonpolyposis Colorectal)http://www2.mdanderson.org/app/pe/index.cfm?pageName=opendoc&docid=2133
ivy.razmus said…
Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA)
http://www.cgaicc.com/
The CGA focuses on families with rare forms of colorectal cancer, including Lynch syndrome.
National Cancer Institute (NCI)
Genetics of Colorectal Cancer
http://www.cancer.gov/cancertopics/pdq/genetics/colorectal/healthprofessional
1-800- 4-CANCER (1-800-422-6237)
Click on the link on the left hand side of the page to access more information on Lynch syndrome.
Cancer.Net

Popular posts from this blog

Get the Facts About Genetic Colon Cancer

Get the Facts: http://genefacts.org Lynch syndrome is a cancer predisposition syndrome caused by inherited mutations in genes responsible for correcting DNA replication errors. Individuals with Lynch syndrome have a greatly increased risk for colorectal, endometrial, and stomach cancers, and a moderately increased risk for other cancers. Key Points 1-3% of colon cancers attributable to Lynch syndrome Dominant inheritance with reduced penetrance (not all patients with mutations will manifest disease) Diagnosis based on clinical and family history, tumor pathology and/or genetic testing Screening and prophylactic surgeries effective in reducing some, but not all cancer risks Mutations in any of several genes can cause the syndrome

Cancer Survivors

Just read a story about one woman's cancer experience. I bet everyone has a story about what goes through your mind when you are told you have cancer. Her thought were about her stunned family members, one crying and the other in shock. I bet there are quite a few stories that could be qualitatively studied. Those experiences could help nurses better help patients during this time.

My Publication, "Hereditary non-polyposis colon cancer: change the name to protect the innocent." Cited in World Journal of Gastroenterology

Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration t... Hsi-Hsien Hsu, Wei-Wen Kuo, Da-Tong Ju... World journal of gastroenterology : WJG 11/2014 20(44):16665-73. World Journal of Gastroenterology : WJG 11/2014; 20(44):16665-73. DOI: 10.3748/wjg.v20.i44.16665 Source: PubMed ABSTRACT To investigate the effects of 17β-estradiol via estrogen receptors (ER) or direct administration of ER agonists on human colorectal cancer. LoVo cells were established from the Bioresource Collection and Research Center and cultured in phenol red-free DMEM (Sigma, United States). To investigate the effects of E2 and/or ER selective agonists on cellular proliferation, LoVo colorectal cells were treated with E2 or ER-selective agonists for 24 h and 48 h and subjected to the MTT (Sigma) assay to find the concentration. And investigate the effects of E2 and/or ER selective agonists on cell used western immunoblotting to find out the diver...